Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology

Abstract

The complement activation system plays important roles to maintain homeostasis in the host and to fight foreign invaders to protect the host. Therefore, the complement system is considered a core part of innate immunity which also cross-talks to acquired immunity. In the history of nephrology, the complement system is familiar to us, because complement protein or fragment deposition, including C3, C4, C1q, and/or C4d, is routinely estimated by immunohistochemistry to diagnose renal pathologies. The relationships between pathological mechanisms and complement activation have been investigated for renal diseases such as post-infectious glomerulonephritis, lupus nephritis, and primary membranoproliferative glomerulonephritis, which are usually accompanied by hypocomplementemia. However, unregulated complement activation in local areas might be associated with progression of various renal injuries even in the normocomplementemic patient. Recently, attention has focused on dysfunction of complement regulation in various diseases including renal diseases such as atypical hemolytic uremic syndrome and C3 glomerulopathy. Some mechanisms associated with complement activation in these diseases were clarified. In addition, lots of anti-complement agents were developed and some of the agents have become clinically available. Now, anti-complement therapies represent a realistic choice of therapeutic approaches for complement-related diseases. Research on roles of complement activation is proceeding into new stages in the field of nephrology and in other fields involving both basic and clinical research. We herein summarize relationships between the complement activation and regulation systems, their physiological effects and roles in maintenance of homeostasis in the host, and how dysregulation of the complement system triggers disease, especially renal disease.

Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway

“…It has been demonstrated that complement activation is involved in the development and progression of FSGS [24,25]. In our study, when treated with adriamycin, the complement system was activated, which is confirmed by the observation of serum C3a and C5a levels, indicating the critical role of complement activation fragments in the pathophysiology of FSGS.…”

Resolution of HBV infection occurs sooner than recovery of renal disease in adult serum HBsAg‐negative HBV–associated glomerulonephritis

“…Among the patients with HBV‐GN who were HBsAg negative, hypocomplementemia was more severe in those positive for HBV markers than in those negative for HBV markers . Complement activation and regulation are thought to be associated with the development and progression of renal injuries . The low complement levels may suggest accelerated consumption of C3 and C4 in the development and maintenance of GN disease.…”

“…11 Complement activation and regulation are thought to be associated with the development and progression of renal injuries. 17 The low complement levels may suggest accelerated consumption of C3 and C4 in the development and maintenance of GN disease.…”

The complex functioning of the complement system in xenotransplantation

“…Complement factors function through specific receptors . To protect self‐tissues from damage, complement regulators (soluble or membrane‐binding cofactor proteins, listed in Table ) monitor the activation of complement factors, and control the reaction to a certain degree and in certain locations . Complement receptor 1 (CR1), membrane cofactor protein (MCP, CD46), decay‐accelerating factor (DAF, CD55), and membrane attack complex inhibitor protein (CD59) are membrane‐bound proteins .…”